220 related articles for article (PubMed ID: 25166349)
1. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
Gómez-Junyent J; Garcia-Vidal C; Viasus D; Millat-Martínez P; Simonetti A; Santos MS; Ardanuy C; Dorca J; Carratalà J
PLoS One; 2014; 9(8):e105854. PubMed ID: 25166349
[TBL] [Abstract][Full Text] [Related]
2. Aetiology of, and risk factors for, recurrent community-acquired pneumonia.
Garcia-Vidal C; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
Clin Microbiol Infect; 2009 Nov; 15(11):1033-8. PubMed ID: 19673961
[TBL] [Abstract][Full Text] [Related]
3. Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes.
Bordon J; Slomka M; Gupta R; Furmanek S; Cavallazzi R; Sethi S; Niederman M; Ramirez JA;
Clin Microbiol Infect; 2020 Feb; 26(2):220-226. PubMed ID: 31254714
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.
Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
PLoS One; 2013; 8(9):e73271. PubMed ID: 24039899
[TBL] [Abstract][Full Text] [Related]
5. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
Dai RX; Kong QH; Mao B; Xu W; Tao RJ; Wang XR; Kong QY; Xu JF
BMC Pulm Med; 2018 Jan; 18(1):12. PubMed ID: 29357862
[TBL] [Abstract][Full Text] [Related]
6. [Pneumonia in the patient with chronic obstructive pulmonary disease. Levels of severity and risk classification].
Ruiz De Oña JM; Gómez Fernández M; Celdrán J; Puente-Maestu L
Arch Bronconeumol; 2003 Mar; 39(3):101-5. PubMed ID: 12622967
[TBL] [Abstract][Full Text] [Related]
7. Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.
Idigo AJ; Wells JM; Brown ML; Wiener HW; Griffin RL; Cutter G; Shrestha S; Lee RA
Antimicrob Resist Infect Control; 2022 Jul; 11(1):95. PubMed ID: 35836272
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
Pifarre R; Falguera M; Vicente-de-Vera C; Nogues A
Respir Med; 2007 Oct; 101(10):2139-44. PubMed ID: 17629470
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.
Liu DS; Han XD; Liu XD
Chin Med J (Engl); 2018 May; 131(9):1086-1091. PubMed ID: 29692381
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
Walters JA; Tang JN; Poole P; Wood-Baker R
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis in patients with pneumonia and chronic obstructive pulmonary disease].
Merino-Sánchez M; Alfageme-Michavila I; Reyes-Núñez N; Lima-Alvarez J
Arch Bronconeumol; 2005 Nov; 41(11):607-11. PubMed ID: 16324599
[TBL] [Abstract][Full Text] [Related]
13. Pneumonia Is Associated with Increased Mortality in Hospitalized COPD Patients: A Systematic Review and Meta-Analysis.
Yu Y; Liu W; Jiang HL; Mao B
Respiration; 2021; 100(1):64-76. PubMed ID: 33454702
[TBL] [Abstract][Full Text] [Related]
14. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
[TBL] [Abstract][Full Text] [Related]
16. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
[TBL] [Abstract][Full Text] [Related]
17. The natural history of community-acquired pneumonia in COPD patients: a population database analysis.
Müllerova H; Chigbo C; Hagan GW; Woodhead MA; Miravitlles M; Davis KJ; Wedzicha JA
Respir Med; 2012 Aug; 106(8):1124-33. PubMed ID: 22621820
[TBL] [Abstract][Full Text] [Related]
18. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores.
Viasus D; Garcia-Vidal C; Castellote J; Adamuz J; Verdaguer R; Dorca J; Manresa F; Gudiol F; Carratalà J
Medicine (Baltimore); 2011 Mar; 90(2):110-118. PubMed ID: 21358441
[TBL] [Abstract][Full Text] [Related]
20. Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients.
Polverino E; Cilloniz C; Menendez R; Gabarrus A; Rosales-Mayor E; Alcaraz V; Terraneo S; Puig de la Bella Casa J; Mensa J; Ferrer M; Torres A
J Infect; 2015 Jul; 71(1):28-36. PubMed ID: 25882347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
